143 related articles for article (PubMed ID: 12379749)
1. E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors.
Volante M; Croce S; Pecchioni C; Papotti M
Mod Pathol; 2002 Oct; 15(10):1038-43. PubMed ID: 12379749
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
3. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
5. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
[TBL] [Abstract][Full Text] [Related]
6. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions.
Letsas KP; Frangou-Lazaridis M; Skyrlas A; Tsatsoulis A; Malamou-Mitsi V
Pathol Int; 2005 Nov; 55(11):694-702. PubMed ID: 16271081
[TBL] [Abstract][Full Text] [Related]
8. E2F-1: a proliferative marker of breast neoplasia.
Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
Zacharatos P; Kotsinas A; Evangelou K; Karakaidos P; Vassiliou LV; Rezaei N; Kyroudi A; Kittas C; Patsouris E; Papavassiliou AG; Gorgoulis VG
J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
12. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas.
Bramis J; Zacharatos P; Papaconstantinou I; Kotsinas A; Sigala F; Korkolis DP; Nikiteas N; Pazaiti A; Kittas C; Bastounis E; Gorgoulis VG
Anticancer Res; 2004; 24(5A):3041-7. PubMed ID: 15517914
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.
Pisani T; Pantellini F; Centanni M; Vecchione A; Giovagnoli MR
Anticancer Res; 2003; 23(4):3323-6. PubMed ID: 12926070
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications.
Russo G; Zamparelli A; Howard CM; Minimo C; Bellan C; Carillo G; Califano L; Leoncini L; Giordano A; Claudio PP
Clin Cancer Res; 2005 May; 11(9):3265-73. PubMed ID: 15867222
[TBL] [Abstract][Full Text] [Related]
15. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle-related gene products in different forms of primary versus recurrent PVNS.
Weckauf H; Helmchen B; Hinz U; Meyer-Scholten C; Aulmann S; Otto HF; Berger I
Cancer Lett; 2004 Jul; 210(1):111-8. PubMed ID: 15172128
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
19. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]